N-(5-(3-(7-(3-Fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide

This compound is typically obtained as an off-white to pale yellow solid. Its molecular formula is C29H24FN7O, corresponding to a molecular weight of 505.55. The melting point is expected to be high, likely exceeding 250 °C, due to the extensive fused aromatic system. The calculated density is approximately 1.35 g/cm³. It is soluble in polar aprotic solvents such as dimethyl sulfoxide and dimethylformamide, moderately soluble in methanol and dichloromethane, and practically insoluble in water and nonpolar solvents like hexane. The molecule contains multiple hydrogen bond donors and acceptors from the amide, indazole NH, and heterocyclic nitrogen atoms. It should be stored in a tightly sealed container under inert atmosphere, protected from light and moisture, at reduced temperature. Contact with strong oxidizing agents and strong bases should be avoided.

This compound is a highly complex, multifunctional heterocyclic molecule featuring several fused ring systems. The core comprises an imidazo[4,5-c]pyridine unit connected to an indazole moiety through a phenyl linkage, with a fluorophenyl substituent on the imidazopyridine ring. Additionally, a pyridin-3-yl group attached to the indazole is further functionalized with a 3-methylbutanamide side chain. The structure incorporates multiple nitrogen-rich heterocycles, which are known to engage in hydrogen bonding and π-stacking interactions with biological targets, particularly kinases. The fluorine atom on the phenyl ring can enhance metabolic stability and binding affinity through electronic effects and halogen bonding. The amide group provides a polar handle for solubility and potential interactions with enzyme active sites. This intricate architecture suggests design for potent and selective inhibition of specific protein kinases, making it a candidate for targeted cancer therapy or other disease-modulating applications.

Kinase Inhibitor Development
This compound is likely investigated as a selective kinase inhibitor, given the prevalence of imidazo[4,5-c]pyridine and indazole scaffolds in ATP-competitive inhibitors. The extended aromatic system can occupy the adenine-binding pocket, while the fluorophenyl and amide substituents may interact with hinge region residues and selectivity pockets. Such inhibitors are explored for treating cancers driven by dysregulated kinase signaling.

Pharmacological Tool Compound
In biochemical and cellular assays, this molecule may serve as a probe to study the function of specific kinases or signaling pathways. Its structural complexity and predicted potency allow researchers to dissect the role of target enzymes in disease models, providing insights into mechanism-based therapeutic strategies.

Lead Optimization Scaffold
The compound represents a lead or intermediate in medicinal chemistry optimization campaigns. The presence of multiple modifiable sites (e.g., amide, pyridine, indazole) enables systematic structure-activity relationship studies to improve potency, selectivity, and pharmacokinetic properties. Derivatives prepared from this scaffold could yield clinical candidates.

Chemical Biology Research
Beyond therapeutic applications, this compound may be employed in chemical biology to elucidate protein-ligand interactions. Its fluorinated aryl group can be exploited for 19F NMR studies to monitor binding events, and its conjugated system may confer fluorescence useful for imaging or biophysical assays.